Sanofi Sponsored ADR Forecast, price target & analysts
Sanofi Sponsored ADR Target price 2025 - Analyst rating & recommendation
Sanofi Sponsored ADR Classifications & Recommendation:
Sanofi Sponsored ADR Price Target
| Target Price | $65.75 |
| Price | $48.05 |
| Potential |
36.83%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Sanofi Sponsored ADR 2026 .
The average Sanofi Sponsored ADR target price is $65.75.
This is
36.83%
register free of charge
$76.79
59.80%
register free of charge
$39.65
17.48%
register free of charge
|
|
| A rating was issued by 29 analysts: 20 Analysts recommend Sanofi Sponsored ADR to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2026 of
36.83%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 51.71 | 53.18 |
| 6.41% | 2.85% | |
| EBITDA Margin | 23.80% | 31.59% |
| 6.03% | 32.73% | |
| Net Margin | 12.55% | 22.91% |
| 3.24% | 82.48% |
25 Analysts have issued a sales forecast Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2025. The average Sanofi Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2025. The average Sanofi Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.16 | 9.72 |
| 2.99% | 88.37% | |
| P/E | 4.94 | |
| EV/Sales | 2.33 |
24 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Sanofi Sponsored ADR...
Current Sanofi Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Jul 13 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Jul 07 2025 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Jul 06 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Jul 15 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jul 13 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Jul 07 2025 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Jul 06 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
